Stock D4S DAIICHI SANKYO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Daiichi Sankyo Co., Ltd. Deutsche Boerse AG

Equities

D4S

JP3475350009

Real-time Estimate Tradegate
Other stock markets
 02:37:17 27/06/2024 pm IST 		5-day change 1st Jan Change
32.17 EUR -0.95% Intraday chart for Daiichi Sankyo Co., Ltd. +0.41% +30.34%
01:45am Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer CI
26/06 Health Care Down as Moderna Slides -- Health Care Roundup DJ

Evolution of the average Target Price on Daiichi Sankyo Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

b20af4b93b16f92c0572c9.df3n9gSR3ewwnD6gF7hTzeSz_x4ni6c9ZQs360Ld0qQ.O6ffgzP1mK9zpEeYVM04h4_RjC5Ws5ZJKlxo3RHto_InnJ2fW8mngW_-dw~49793d814e63bb2dd0f4cdabd4e9483f

Analyst Recommendations on Daiichi Sankyo Co., Ltd.

Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy MT
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold MT
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy MT
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy MT
Nikkei little changed, pinned down by rates worry RE
Japan's Nikkei snaps 5-day losing streak amid US rate caution RE
MARKETSCREENER'S WORLD PRESS REVIEW : June 6, 2022 Our Logo
FTSE Flat, PMI Data Adds to Case for Another BoE Rate Increase DJ
AstraZeneca-Daiichi Sankyo's Enhertu Improves Progression-Free Survival, Objective Response Rate in Brain Metastases Patients MT
AstraZeneca : Daiichi Sankyo's Enhertu Shows 55% Tumor Response Rate in Lung Cancer Patients MT
Japanese shares jump on Fed's growth view, rate pledge RE
Daiichi Sankyo Company, Limited Announces New 12-Month Analysis Data from ETNA-AF Non-Interventional Study Show Low Bleeding and ICH Rates in Frail and Ageing AF Patients on LIXIANA CI
Japanese stocks slip as economy shrinks at record rate on pandemic hit RE
Astrazeneca and Daiichi Sankyo Company, Limited Announces ENHERTU (Fam-Trastuzumab Deruxtecan-Nxki) Significantly Improved Tumor Response Rate and Overall Survival in HER2-Positive Metastatic Gastric Cancer in Phase II Destiny-Gastric01 Trial CI
Royal Philips : AstraZeneca raises sales forecast after second quarter cancer drug, China boost RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,652 JPY
Average target price
6,177 JPY
Spread / Average Target
+9.28%
High Price Target
6,800 JPY
Spread / Highest target
+20.31%
Low Price Target
4,900 JPY
Spread / Lowest Target
-13.31%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Daiichi Sankyo Co., Ltd.

Jefferies & Co.

Ratings for Daiichi Sankyo Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. D4S Stock
  5. Consensus Daiichi Sankyo Co., Ltd.